The company develops business in partnership with the world's leading manufacturers of innovative medical products. One of the key factors of the company's success is the continuous improvement of integrated solutions for various therapeutic areas, ranging from diagnostics and treatment at the hospital stage to providing preferential categories of citizens with high—quality medical products throughout Russia.
According to IQVIA, Lancet Group is among the TOP 10 largest Russian distributors in the gross sales market, having increased its sales by 53% compared to the same period last year. According to the results of the 1st quarter of 2022 GC Lancet:
Retains 2nd place among distributors in terms of secondary sales*
Holds its position in the TOP 10 of all pharmaceutical distributors of the Russian Federation in terms of budget sales*
Data source: *IQVIA
